N-0901 | Neuropeptide FF F-8-F-NH2, NPFF, F-8-F-amide |
C54H76N14O10 | 1081.29 | 99566-27-5 | H-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 |
N-0902 | (D-Tyr1,N-Me-Phe3)-Neuropeptide FF | C55H78N14O11 | 1111.31 | 145274-93-7 | H-D-Tyr-Leu-N-Me-Phe-Gln-Pro-Gln-Arg-Phe-NH2 |
N-0903 | RF9 | C26H38N6O3 | 482.63 | 876310-60-0 | 1-Adamantanecarbonyl-Arg-Phe-NH2 |
N-1001 | Neuropeptide S (1-10) (human) | C42H68N14O14S | 1025.15 | 904910-39-0 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-OH |
N-1002 | Neuropeptide S (human) NPS (human) |
C93H155N31O28S | 2187.51 | 412938-67-1 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser-OH |
N-1003 | Neuropeptide S (rat) NPS (rat) |
C95H160N34O27 | 2210.53 | 412938-75-1 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Ser-Gly-Val-Lys-Lys-Thr-Ser-Phe-Arg-Arg-Ala-Lys-Gln-OH |
N-1101 | Neuropeptide W-23 (human) NPW-23 (human) |
C119H183N35O28S | 2584.05 | 383415-79-0 | H-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-OH |
N-1102 | Biotinyl-Neuropeptide W-23 (human) Biotinyl-NPW-23 (human) |
C129H197N37O30S2 | 2810.35 | Biotinyl-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-OH | |
N-1103 | Neuropeptide W-23 (rat) rPPL8 (42-64), Preproprotein L8 (42-64) (rat), rL8, NPW-23 (rat) |
C119H183N35O29S | 2600.05 | 383415-89-2 | H-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Met-Gly-Leu-OH |
N-1201 | Neuropeptide W-30 (human) NPW-30 (human), hPPL8 (33-62), Preproprotein L8 (33-62) (rat), hL8C |
C165H249N49O37S | 3543.17 | 383415-80-3 | H-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp-OH |